New Treatment Standards in Uro-Oncological Diseases with High Unmet Need
Jeff Bova, Chief Commercial Officer at UroGen Pharma discusses the launch of their first FDA-approved treatment, the only non-surgical option for patients with low-grade upper tract urothelial carcinoma, or LG-UTUC. This is the first of UroGen medicines to demonstrate an industry-leading move towards more innovative, non-surgical options for patients. He shares UroGen’s vision to fundamentally change the treatment model for some of the most devastating cancers by delivering better medicines to patients in ways never done before.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Jeff Bova, Chief Commercial Officer at UroGen Pharma.
Jeff is an experienced pharmaceutical industry executive with extensive leadership experience in national sales, marketing, and managed care. Jeff joined UroGen in 2017 as Vice President and Head of Commercial, and now serves as the Chief Commercial Officer. Prior to UroGen, Jeff held multiple senior-level sales leadership positions at Bayer Healthcare and most recently served as Vice President of Oncology Sales, where he led a field sales force of more than 200 in marketing brands. Jeff holds a master’s degree in business administration from Xavier University and a Bachelor of Science in finance and marketing from the University of Cincinnati.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
